Sterling Biotech Limited announced earnings results for the full year ended March 31, 2020. For the full year, the company announced total revenue was INR 3,498.991 million compared to INR 3,518.632 million a year ago. Net loss was INR 4,323.517 million compared to INR 33,311.158 million a year ago. Basic loss per share from continuing operations was INR 15.89 compared to INR 122.39 a year ago.